DEK over-expression promotes mitotic defects and micronucleus formation

References

• Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004; 432:338-41; PMID:15549096; http://dx.doi.org/10.1038/nature03099
   PubMed Web of Science ®Google Scholar
• Boveri T. über mehrpolige Mitosen als Mittel zur Analyse des Zellkerns. Verhandlungen der physicalisch-medizinischen Gesselschaft zu Würzburg Neu Folge 1902; 67-90.
   Google Scholar
• Boveri TGF. Zur Frage der Entstehung maligner Tumoren (The origin of malignant tumors). Gustav Fischer; 1914.
   Google Scholar
• Weaver BA, Cleveland DW. Does aneuploidy cause cancer? Curr Opin Cell Biol 2006; 18:658-67; PMID:17046232; http://dx.doi.org/10.1016/j.ceb.2006.10.002
   PubMed Web of Science ®Google Scholar
• Duesberg P, Rausch C, Rasnick D, Hehlmann R. Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc Natl Acad Sci U S A 1998; 95:13692-7; PMID:9811862; http://dx.doi.org/10.1073/pnas.95.23.13692
   PubMed Web of Science ®Google Scholar
• Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet 2002; 36:617-56; PMID:12429704; http://dx.doi.org/10.1146/annurev.genet.36.060402.113540
   PubMed Web of Science ®Google Scholar
• Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005; 5:773-85; PMID:16195750; http://dx.doi.org/10.1038/nrc1714
   PubMed Web of Science ®Google Scholar
• Fenech M, Kirsch-Volders M, Natarajan AT, Surralles J, Crott JW, Parry J, Norppa H, Eastmond DA, Tucker JD, Thomas P. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis 2011; 26:125-32; PMID:21164193; http://dx.doi.org/10.1093/mutage/geq052
   PubMed Web of Science ®Google Scholar
• Bakhoum SF, Genovese G, Compton DA. Deviant kinetochore microtubule dynamics underlie chromosomal instability. Curr Biol 19:1937-42; PMID:19879145; http://dx.doi.org/10.1016/j.cub.2009.09.055
   PubMed Web of Science ®Google Scholar
• Weaver BAA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW. Aneuploidy Acts Both Oncogenically and as a Tumor Suppressor. Cancer Cell 2007; 11:25-36; PMID:17189716; http://dx.doi.org/10.1016/j.ccr.2006.12.003
   PubMed Web of Science ®Google Scholar
• Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV, Benezra R. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 2001:409, 355-9; PMID:11201745; http://dx.doi.org/10.1038/35053094
   PubMed Web of Science ®Google Scholar
• Rehen SK, McConnell MJ, Kaushal D, Kingsbury MA, Yang AH, Chun J. Chromosomal variation in neurons of the developing and adult mammalian nervous system. Proc Natl Acad Sci 2001; 98:13361-6; http://dx.doi.org/10.1073/pnas.231487398
   PubMed Web of Science ®Google Scholar
• Amato A, Lentini L, Schillaci T, Iovino F, Di Leonardo A. RNAi mediated acute depletion of Retinoblastoma protein (pRb) promotes aneuploidy in human primary cells via micronuclei formation. BMC Cell Biol 2009; 10:79; PMID:19883508; http://dx.doi.org/10.1186/1471-2121-10-79
   PubMed Web of Science ®Google Scholar
• Fenech M. Cytokinesis-block micronucleus assay evolves into a “cytome” assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res 2006; 600:58-66; PMID:16822529; http://dx.doi.org/10.1016/j.mrfmmm.2006.05.028
   PubMed Web of Science ®Google Scholar
• Lund T, Laland SG. The metaphase specific phosphorylation of HMG I. Biochem Biophys Res Commun 1990; 171:342-7; PMID:2168176; http://dx.doi.org/10.1016/0006-291X(90)91399-D
   PubMed Web of Science ®Google Scholar
• Prymakowska-Bosak M, Misteli T, Herrera JE, Shirakawa H, Birger Y, Garfield S, Bustin M. Mitotic phosphorylation prevents the binding of HMGN proteins to chromatin. Mol Cell Biol 2001; 21:5169-78; PMID:11438671; http://dx.doi.org/10.1128/MCB.21.15.5169-5178.2001
   PubMed Web of Science ®Google Scholar
• Waldmann T, Eckerich C, Baack M, Gruss C. The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils. J Biol Chem 2002; 277:24988-94; PMID:11997399; http://dx.doi.org/10.1074/jbc.M204045200
   PubMed Web of Science ®Google Scholar
• Sawatsubashi S, Murata T, Lim J, Fujiki R, Ito S, Suzuki E, Tanabe M, Zhao Y, Kimura S, Fujiyama S, et al. A histone chaperone, DEK, transcriptionally coactivates a nuclear receptor. Genes Dev 2010; 24:159-70; PMID:20040570; http://dx.doi.org/10.1101/gad.1857410
   PubMed Web of Science ®Google Scholar
• Ivanauskiene K, Delbarre E, McGhie JD, Küntziger T, Wong LH, Collas P. The PML-associated protein DEK regulates the balance of H3.3 loading on chromatin and is important for telomere integrity. Genome Res 2014; 24:1584-94; PMID:25049225; http://dx.doi.org/10.1101/gr.173831.114
   PubMed Web of Science ®Google Scholar
• Kappes F, Waldmann T, Mathew V, Yu J, Zhang L, Khodadoust MS, Chinnaiyan AM, Luger K, Erhardt S, Schneider R, et al. The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity. Genes Dev 2011; 25:673-8; PMID:21460035; http://dx.doi.org/10.1101/gad.2036411
   PubMed Web of Science ®Google Scholar
• Carro MS, Spiga FM, Quarto M, Di Ninni V, Volorio S, Alcalay M, Müller H. DEK Expression is controlled by E2F and deregulated in diverse tumor types. Cell Cycle (Georgetown, Tex.) 2006; 5, 1202-7; PMID:16721057; http://dx.doi.org/10.4161/cc.5.11.2801
   PubMed Web of Science ®Google Scholar
• Grasemann C, Gratias S, Stephan H, Schüler A, Schramm A, Klein-Hitpass L, Rieder H, Schneider S, Kappes F, Eggert A, et al. Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma. Oncogene 2005; 24:6441-9; PMID:16007192; http://dx.doi.org/10.1038/sj.onc.1208792
   PubMed Web of Science ®Google Scholar
• von Lindern M, Fornerod M, Soekarman N, van Baal S, Jaegle M, Hagemeijer A, Bootsma D, Grosveld G, et al. Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene. Bailliere's Clin Haematol 1992; 5:857-79; PMID:1308167; http://dx.doi.org/10.1016/S0950-3536(11)80049-1
   PubMed Web of Science ®Google Scholar
• Wu Q, Hoffmann MJ, Hartmann FH, Schulz WA. Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer. Mol Cancer 2005; 4:16; PMID:15876350; http://dx.doi.org/10.1186/1476-4598-4-16
   PubMed Web of Science ®Google Scholar
• Privette Vinnedge LM, Ho SM, Wikenheiser-Brokamp KA, Wells SI. The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer. PloS One 2012; 7:e46985; PMID:23071688; http://dx.doi.org/10.1371/journal.pone.0046985
   PubMed Web of Science ®Google Scholar
• Theurillat J-P, Udeshi ND, Errington WJ, Svinkina T, Baca SC, Pop M, Wild PJ, Blattner M, Groner AC, Rubin MA, et al. SPOP mutations alter the Ubiquitin landscape in prostate cancer. Cancer Discov 2014; 4:Of19; http://dx.doi.org/10.1158/2159-8290.cd-rw2014-214
   Google Scholar
• Babaei-Jadidi R, Li N, Saadeddin A, Spencer-Dene B, Jandke A, Muhammad B, Ibrahim EE, Muraleedharan R, Abuzinadah M, Davis H, et al. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation. J Exp Med 2011; 208:295-312; PMID:21282377; http://dx.doi.org/10.1084/jem.20100830
   PubMed Web of Science ®Google Scholar
• Wise-Draper TM, Allen HV, Thobe MN, Jones EE, Habash KB, Münger K, Wells SI. The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7. J Virol 2005; 79:14309-17; PMID:16254365; http://dx.doi.org/10.1128/JVI.79.22.14309-14317.2005
   PubMed Web of Science ®Google Scholar
• Wise-Draper TM, Mintz-Cole RA, Morris TA, Simpson DS, Wikenheiser-Brokamp KA, Currier MA, Cripe TP, Grosveld GC, Wells SI. Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo. Cancer Res 2009; 69:1792-9; PMID:19223548; http://dx.doi.org/10.1158/0008-5472.CAN-08-2304
   PubMed Web of Science ®Google Scholar
• Wise-Draper TM, Morreale RJ, Morris TA, Mintz-Cole RA, Hoskins EE, Balsitis SJ, Husseinzadeh N, Witte DP, Wikenheiser-Brokamp KA, Lambert PF, et al. DEK proto-oncogene expression interferes with the normal epithelial differentiation program. A J Pathol 2009; 174:71-81; PMID:19036808; http://dx.doi.org/10.2353/ajpath.2009.080330
   PubMed Web of Science ®Google Scholar
• Privette Vinnedge LM, McClaine R, Wagh PK, Wikenheiser-Brokamp KA, Waltz SE, Wells SI. The human DEK oncogene stimulates beta-catenin signaling, invasion and mammosphere formation in breast cancer. Oncogene 2011; 30:2741-52; PMID:21317931; http://dx.doi.org/10.1038/onc.2011.2
   PubMed Web of Science ®Google Scholar
• Deutzmann A, Ganz M, Schönenberger F, Vervoorts J, Kappes F, Ferrando-May E. The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress. Oncogene 2014; Epub ahead of print; PMID:25347734; http://dx.doi.org/10.1038/onc.2014.346
   PubMed Web of Science ®Google Scholar
• Bohm F, Kappes F, Scholten I, Richter N, Matsuo H, Knippers R, Waldmann T. The SAF-box domain of chromatin protein DEK. Nucleic acids Res 2005; 33:1101-10; PMID:15722484; http://dx.doi.org/10.1093/nar/gki258
   PubMed Web of Science ®Google Scholar
• Kappes F, Scholten I, Richter N, Gruss C, Waldmann T. Functional domains of the ubiquitous chromatin protein DEK. Mol Cell Biol 2004; 24:6000-10; PMID:15199153; http://dx.doi.org/10.1128/MCB.24.13.6000-6010.2004
   PubMed Web of Science ®Google Scholar
• Campillos M, Garcia MA, Valdivieso F, Vazquez J. Transcriptional activation by AP-2alpha is modulated by the oncogene DEK. Nucleic Acids Res 2003; 31:1571-5; PMID:12595566; http://dx.doi.org/10.1093/nar/gkg247
   PubMed Web of Science ®Google Scholar
• Sammons M, Wan SS, Vogel NL, Mientjes EJ, Grosveld G, Ashburner BP. Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene. J Biol Chem 2006; 281:26802-12; PMID:16829531; http://dx.doi.org/10.1074/jbc.M600915200
   PubMed Web of Science ®Google Scholar
• Kavanaugh GM, Wise-Draper TM, Morreale RJ, Morrison MA, Gole B, Schwemberger S, Tichy ED, Lu L, Babcock GF, Wells JM, et al. The human DEK oncogene regulates DNA damage response signaling and repair. Nucleic Acids Res 2011; 39:7465-76; PMID:21653549; http://dx.doi.org/10.1093/nar/gkr454
   PubMed Web of Science ®Google Scholar
• Kappes F, Damoc C, Knippers R, Przybylski M, Pinna LA, Gruss C. Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK. Mol Cell Biol 2004; 24:6011-20; PMID:15199154; http://dx.doi.org/10.1128/MCB.24.13.6011-6020.2004
   PubMed Web of Science ®Google Scholar
• Cleary J, Sitwala KV, Khodadoust MS, Kwok RP, Mor-Vaknin N, Cebrat M, Cole PA, Markovitz DM. p300/CBP-associated factor drives DEK into interchromatin granule clusters. J Biol Chem 2005; 280:31760-7; PMID:15987677; http://dx.doi.org/10.1074/jbc.M500884200
   PubMed Web of Science ®Google Scholar
• Kappes F, Fahrer J, Khodadoust MS, Tabbert A, Strasser C, Mor-Vaknin N, Moreno-Villanueva M, Bürkle A, Markovitz DM, Ferrando-May E. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress. Mol Cell Biol 2008; 28:3245-57; PMID:18332104; http://dx.doi.org/10.1128/MCB.01921-07
   PubMed Web of Science ®Google Scholar
• Privette Vinnedge LM, Kappes F, Nassar N, Wells SI. Stacking the DEK: from chromatin topology to cancer stem cells. Cell Cycle (Georgetown, Tex.) 2013; 12:51-66; PMID:23255114; http://dx.doi.org/10.4161/cc.23121
   PubMed Web of Science ®Google Scholar
• Waldmann T, Scholten I, Kappes F, Hu HG, Knippers R. The DEK protein–an abundant and ubiquitous constituent of mammalian chromatin. Gene 2004; 343:1-9; PMID:15563827; http://dx.doi.org/10.1016/j.gene.2004.08.029
   PubMed Web of Science ®Google Scholar
• Fornerod M, Fahrer J, Khodadoust MS, Tabbert A, Strasser C, Mor-Vaknin N, Moreno-Villanueva M, Bürkle A, Markovitz DM, Ferrando-May E. Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene 1995; 10:1739-48; PMID:7753551
   PubMed Web of Science ®Google Scholar
• Gassmann R, Henzing AJ, Earnshaw WC. Novel components of human mitotic chromosomes identified by proteomic analysis of the chromosome scaffold fraction. Chromosoma 2005; 113:385-97; PMID:15609038; http://dx.doi.org/10.1007/s00412-004-0326-0
   PubMed Web of Science ®Google Scholar
• Allen-Hoffmann BL, Schlosser SJ, Ivarie CA, Sattler CA, Meisner LF, O'Connor SL. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. The J Invest Dermatol 2000; 114:444-55; PMID:10692102; http://dx.doi.org/10.1046/j.1523-1747.2000.00869.x
   PubMed Web of Science ®Google Scholar
• Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, et al. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 2007; 28:625-31; PMID:16973674; http://dx.doi.org/10.1093/carcin/bgl177
   PubMed Web of Science ®Google Scholar
• Ramirez A, Saldanha PH. Micronucleus investigation of alcoholic patients with oral carcinomas. Genet Mol Res 2002; 1:246-60; PMID:14963832
   PubMedGoogle Scholar
• Kaur J, Dey P. Micronucleus to distinguish adenocarcinoma from reactive mesothelial cell in effusion fluid. Diagn Cytopathol 2010; 38:177-9; PMID:19693939
   PubMed Web of Science ®Google Scholar
• Samanta S, Dey P, Gupta N, Mouleeswaran KS, Nijhawan R. Micronucleus in atypical squamous cell of undetermined significance. Diagn Cytopathol 2011; 39:242-4; PMID:21416636; http://dx.doi.org/10.1002/dc.21368
   PubMed Web of Science ®Google Scholar
• Arora SK, Dey P, Saikia UN. Micronucleus in atypical urothelial cells. Diagn Cytopathol 2010; 38:811-3; PMID:20049965; http://dx.doi.org/10.1002/dc.21297
   PubMed Web of Science ®Google Scholar
• Kappes F, Burger K, Baack M, Fackelmayer FO, Gruss C. Subcellular localization of the human proto-oncogene protein DEK. J Biol Chem 2001; 276:26317-23; PMID:11333257; http://dx.doi.org/10.1074/jbc.M100162200
   PubMed Web of Science ®Google Scholar
• Adams AK, Hallenbeck GE, Casper KA, Patil YJ, Wilson KM, Kimple RJ, Lambert PF, Witte DP, Xiao W, Gillison ML, et al. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation. Oncogene 2014; 0:1; PMID:24608431; http://dx.doi.org/10.1038/onc.2014.15
   PubMed Web of Science ®Google Scholar
• Kim DW, Kim JY, Choi S, Rhee S, Hahn Y, Seo SB. Transcriptional regulation of 1-cys peroxiredoxin by the proto-oncogene protein DEK. Mol Med Rep 2010; 3:877-81; PMID:21472329; http://dx.doi.org/10.3892/mmr.2010.346
   PubMed Web of Science ®Google Scholar
• Liu K, Feng T, Liu J, Zhong M, Zhang S. Silencing of the DEK gene induces apoptosis and senescence in CaSki cervical carcinoma cells via the up-regulation of NF-kappaB p65. Biosci Rep 2012; 32:323-32; PMID:22390170; http://dx.doi.org/10.1042/BSR20100141
   PubMed Web of Science ®Google Scholar
• Karam M, Thenoz M, Capraro V, Robin JP, Pinatel C, Lancon A, Galia P, Sibon D, Thomas X, Ducastelle-Lepretre S, et al. Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias. Neoplasia (New York, N.Y.) 2014; 16:21-30; PMID:24563617
   PubMed Web of Science ®Google Scholar
• Gamble MJ, Fisher RP. SET and PARP1 remove DEK from chromatin to permit access by the transcription machinery. Nat Struct Mol Biol 2007; 14:548-55; PMID:17529993; http://dx.doi.org/10.1038/nsmb1248
   PubMed Web of Science ®Google Scholar
• Koleva RI, Ficarro SB, Radomska HS, Carrasco-Alfonso MJ, Alberta JA, Webber JT, Luckey CJ, Marcucci G, Tenen DG, Marto JA, et al. C/EBPalpha and DEK coordinately regulate myeloid differentiation. Blood 2012; 119:4878-88; PMID:22474248; http://dx.doi.org/10.1182/blood-2011-10-383083
   PubMed Web of Science ®Google Scholar
• Wong C, Stearns T. Mammalian cells lack checkpoints for tetraploidy, aberrant centrosome number, and cytokinesis failure. BMC Cell Biol 2005; 6:6; PMID:15713235; http://dx.doi.org/10.1186/1471-2121-6-6
   PubMed Web of Science ®Google Scholar
• Attia SM, Ahmad SF, Okash RM, Bakheet SA. Dominant lethal effects of nocodazole in germ cells of male mice. Food Chem Toxicol 2015; 77:101-4; PMID:25595372; http://dx.doi.org/10.1016/j.fct.2015.01.004
   PubMed Web of Science ®Google Scholar
• Endo K, Mizuguchi M, Harata A, Itoh, G, Tanaka K. Nocodazole induces mitotic cell death with apoptotic-like features in Saccharomyces cerevisiae. FEBS Lett 2010; 584:2387-92; PMID:20399776; http://dx.doi.org/10.1016/j.febslet.2010.04.029
   PubMed Web of Science ®Google Scholar
• Giunta S, Belotserkovskaya R, Jackson SP. DNA damage signaling in response to double-strand breaks during mitosis. J Cell Biol 2010; 190:197-207; PMID:20660628; http://dx.doi.org/10.1083/jcb.200911156
   PubMed Web of Science ®Google Scholar
• Dutertre S, Ababou M, Onclercq R, Delic J, Chatton B, Jaulin C, Amor-Guéret M. Cell cycle regulation of the endogenous wild type Bloom's syndrome DNA helicase. Oncogene 2000; 19:2731-8; PMID:10851073; http://dx.doi.org/10.1038/sj.onc.1203595
   PubMed Web of Science ®Google Scholar
• Koike M, Awaji T, Kataoka M, Tsujimoto G, Kartasova T, Koike A, Shiomi T. Differential subcellular localization of DNA-dependent protein kinase components Ku and DNA-PKcs during mitosis. J Cell Sci 1999; 112 (Pt 22):4031-9; PMID:10547363
   PubMed Web of Science ®Google Scholar
• Chan KL, Palmai-Pallag T, Ying S, Hickson ID. Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat Cell Biol 2009; 11:753-60; PMID:19465922; http://dx.doi.org/10.1038/ncb1882
   PubMed Web of Science ®Google Scholar
• Cappelli E, Townsend S, Griffin C, Thacker J. Homologous recombination proteins are associated with centrosomes and are required for mitotic stability. Exp Cell Res 2011; 317:1203-13; PMID:21276791; http://dx.doi.org/10.1016/j.yexcr.2011.01.021
   PubMed Web of Science ®Google Scholar
• Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis 2010; 3:ra3; PMID:20068231
   PubMedGoogle Scholar
• Avila J, Ulloa L, Gonzalez J, Moreno F, Diaz-Nido J. Phosphorylation of microtubule-associated proteins by protein kinase CK2 in neuritogenesis. Cell Mol Biol Res 1994; 40:573-9; PMID:7537578
   PubMedGoogle Scholar
• Glover CV 3rd. On the physiological role of casein kinase II in Saccharomyces cerevisiae. Prog Nucleic Acid Res Mol Biol 1998; 59:95-133; PMID:9427841; http://dx.doi.org/10.1016/S0079-6603(08)61030-2
   PubMed Web of Science ®Google Scholar
• Lorenz P, Pepperkok R, Ansorge W, Pyerin W. Cell biological studies with monoclonal and polyclonal antibodies against human casein kinase II subunit beta demonstrate participation of the kinase in mitogenic signaling. J Biol Chem 1993; 268:2733-9; PMID:8428947
   PubMed Web of Science ®Google Scholar
• Faust M, Schuster N, Montenarh M. Specific binding of protein kinase CK2 catalytic subunits to tubulin. FEBS Lett 1999; 462:51-6; PMID:10580090; http://dx.doi.org/10.1016/S0014-5793(99)01492-1
   PubMed Web of Science ®Google Scholar
• Petersen DF, Anderson EC, Tobey RA. Mitotic Cells As A Source Of Synchronized Cultures. DM Prescott (Ed.) Academic Press, New York 1968; 3:347-70
   Google Scholar
• Williams DA, Tao W, Yang F, Kim C, Gu Y, Mansfield P, Levine JE, Petryniak B, Derrow CW, Harris C, Jia B, et al. Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 2000; 96:1646-54; PMID:10961859
   PubMed Web of Science ®Google Scholar
• Avlasevich S, Bryce S, De Boeck M, Elhajouji A, Van Goethem F, Lynch A, Nicolette J, Shi J, Dertinger S. Flow cytometric analysis of micronuclei in mammalian cell cultures: past, present and future. Mutagenesis 2011; 26:147-52; PMID:21164196; http://dx.doi.org/10.1093/mutage/geq058
   PubMed Web of Science ®Google Scholar
• Bryce SM, Avlasevich SL, Bemis JC, Dertinger SD. Miniaturized flow cytometry-based CHO-K1 micronucleus assay discriminates aneugenic and clastogenic modes of action. Environ Mol Mutagen 2011; 52:280-6; PMID:20872831; http://dx.doi.org/10.1002/em.20618
   PubMed Web of Science ®Google Scholar
• Bryce SM, Bemis JC, Avlasevich SL, Dertinger SD. In vitro micronucleus assay scored by flow cytometry provides a comprehensive evaluation of cytogenetic damage and cytotoxicity. Mutat Res Genet Toxicol Environ Mutagen 2007; 630:78-91; http://dx.doi.org/10.1016/j.mrgentox.2007.03.002
   PubMed Web of Science ®Google Scholar
• Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 2009; 37:W305-311; PMID:19465376; http://dx.doi.org/10.1093/nar/gkp427
   PubMed Web of Science ®Google Scholar